- Home
- ALGS vs FSEA Comparison
ALGS vs FSEA Comparison
Compare ALGS & FSEA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ALGS
- FSEA
- Stock Information
- Founded
- ALGS 2018
- FSEA 1890
- Country
- ALGS United States
- FSEA United States
- Employees
- ALGS N/A
- FSEA N/A
- Industry
- ALGS Biotechnology: Pharmaceutical Preparations
- FSEA Savings Institutions
- Sector
- ALGS Health Care
- FSEA Finance
- Exchange
- ALGS Nasdaq
- FSEA Nasdaq
- Market Cap
- ALGS 53.0M
- FSEA 53.7M
- IPO Year
- ALGS 2020
- FSEA N/A
- Fundamental
- Price
- ALGS $11.34
- FSEA $11.68
- Analyst Decision
- ALGS Strong Buy
- FSEA
- Analyst Count
- ALGS 2
- FSEA 0
- Target Price
- ALGS $60.00
- FSEA N/A
- AVG Volume (30 Days)
- ALGS 74.9K
- FSEA 3.2K
- Earning Date
- ALGS 11-05-2025
- FSEA 11-07-2025
- Dividend Yield
- ALGS N/A
- FSEA N/A
- EPS Growth
- ALGS N/A
- FSEA N/A
- EPS
- ALGS N/A
- FSEA N/A
- Revenue
- ALGS $3,174,000.00
- FSEA $14,095,000.00
- Revenue This Year
- ALGS N/A
- FSEA N/A
- Revenue Next Year
- ALGS $28.79
- FSEA N/A
- P/E Ratio
- ALGS N/A
- FSEA N/A
- Revenue Growth
- ALGS N/A
- FSEA 30.26
- 52 Week Low
- ALGS $3.76
- FSEA $8.90
- 52 Week High
- ALGS $46.80
- FSEA $11.95
- Technical
- Relative Strength Index (RSI)
- ALGS 70.84
- FSEA 58.10
- Support Level
- ALGS $10.01
- FSEA $11.43
- Resistance Level
- ALGS $10.86
- FSEA $11.95
- Average True Range (ATR)
- ALGS 0.97
- FSEA 0.15
- MACD
- ALGS 0.13
- FSEA 0.01
- Stochastic Oscillator
- ALGS 90.81
- FSEA 70.96
About ALGS Aligos Therapeutics Inc.
Aligos Therapeutics Inc is a clinical stage biopharmaceutical company. It is engaged in developing novel therapeutics to address unmet medical needs in viral and liver diseases, including chronic hepatitis B and coronaviruses, and therapeutics for nonalcoholic steatohepatitis (NASH). The company's pipeline includes ALG-010133, ALG-000184, ALG-020572 and ALG-055009, among others.
About FSEA First Seacoast Bancorp Inc.
First Seacoast Bancorp Inc is a savings and loan holding company. Its business consists of taking deposits from the general public and investing those deposits, together with funds generated from operations and borrowings from the Federal Home Loan Bank, in one-to-four-family residential real estate loans, commercial real estate, and multi-family real estate loans, acquisition, development and land loans, commercial and industrial loans, home equity loans and lines of credit and consumer loans. The company generates revenue from financial instruments, such as loans, letters of credit, and investment securities, as well as revenue related to mortgage servicing activities, and bank-owned life insurance.